Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj

Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis

NCT00665925 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Pf-06650833 In Subjects With Rheumatoid Arthritis, With An Inadequate Response To Methotrexate

NCT02996500 ·Status: COMPLETED ·Phase: PHASE2

An Observational Study on Long-Term Efficacy and Safety of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis (FAct)

NCT01483326 ·Status: COMPLETED

A Study of Filgotinib in Korean Participants With Rheumatoid Arthritis

NCT06625242 ·Status: COMPLETED ·Phase: PHASE4

A Study to Compare FKB327 Long-term Safety, Efficacy and Immunogenicity With Humira® in Rheumatoid Arthritis Patients

NCT02405780 ·Status: COMPLETED ·Phase: PHASE3

A Study of Rituximab (MabThera®/Rituxan®) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate

NCT00578305 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (RA)

NCT01242514 ·Status: TERMINATED ·Phase: PHASE3

Study to Evaluate the Efficacy and Safety of GSK3196165 Plus Methotrexate in Subjects With Active Moderate-Severe Rheumatoid Arthritis

NCT02504671 ·Status: COMPLETED ·Phase: PHASE2

Longterm Followup of Patients With Rheumatoid Arthritis Treated With Methotrexate

NCT02641977 ·Status: COMPLETED

Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate

NCT00235859 ·Status: COMPLETED ·Phase: PHASE3

Observational Study of Rituxan in Rheumatoid Arthritis Patients in Routine Clinical Practice

NCT00984711 ·Status: UNKNOWN

Study To Assess The Efficacy And Safety Of Pf-06651600 In Subjects With Rheumatoid Arthritis With An Inadequate Response To Methotrexate

NCT02969044 ·Status: COMPLETED ·Phase: PHASE2

An Open-label Study of GC012F in Rheumatoid Arthritis.

NCT07315503 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With RA

NCT02557295 ·Status: TERMINATED

A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)

NCT01362153 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis (Taski-3)

NCT00665626 ·Status: COMPLETED ·Phase: PHASE2

A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients

NCT02260791 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess CH1504 in Patients With Active Rheumatoid Arthritis

NCT00658047 ·Status: COMPLETED ·Phase: PHASE2

An Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis

NCT07029555 ·Status: RECRUITING ·Phase: PHASE1

A Long Term Study to Assess the Safety of Fostamatinib in Patients in Asia With Rheumatoid Arthritis

NCT01640054 ·Status: TERMINATED ·Phase: PHASE2

Stem Cell Support in Patients With Rheumatoid Arthritis

NCT00278551 ·Status: TERMINATED ·Phase: PHASE1

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effects of Multiple Rising Subcutaneous Doses of BI 655064 in Healthy Volunteers and in Rheumatoid Arthritis Patients With Prior Inadequate Response to Methotrexate Therapy

NCT01751776 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients

NCT01061736 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Effect of Subcutaneous ACTEMRA on Inflamed Atherosclerotic Plaques in Patients With Rheumatoid Arthritis

NCT02659150 ·Status: TERMINATED ·Phase: PHASE4

A Study of the Effectiveness and Safety of Ustekinumab (STELARA) and CNTO 1959 Administered Under the Skin of Patients With Active Rheumatoid Arthritis, Despite Existing Methotrexate Therapy

NCT01645280 ·Status: COMPLETED ·Phase: PHASE2